PACB
Pacific Biosciences of CaliforniaDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
PACB vs peer average
30/100
PACB vs. peer average (D vs. C)
Grade spread
B 4 · C 3 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
PBYI is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $436.72M
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
PACB
Pacific Biosciences of California
PBYI
Puma Biotechnology
Grade
D
B
Momentum
45
71
Value
41
70
Sentiment
-
28
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs PBYI
PACB / PBYI
Grade Position
Below peers
PACB vs. peer average (D vs. C)
30/100
Momentum
45
PBYIValue
41
PBYISentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs PACB
PBYI is the first peer returned for this comparison set.